Similar Posts
The U.S.-Canada Trade War Is Getting Bigger: Which Industries Could Win and Lose?
A New Phase in North American Trade Trade tensions between the United States and Canada have escalated sharply. After negotiations broke down, President Donald Trump threatened to raise tariffs on Canadian cars, trucks, automotive parts and steel to 50% from January 1, 2027. Canada has also announced retaliatory measures on selected U.S. goods beginning September…
Jaguar Mining Inc. (TSE: JAG): Maintains Steady Growth
Jaguar Mining Inc. (TSE: JAG) is a Canadian gold mining, development, and exploration company headquartered in Toronto, Ontario. It operates primarily in Brazil’s Iron Quadrangle, a historic and prolific gold-producing region in Minas Gerais. The company owns and manages the Turmalina Gold Mine and the Caeté Complex, which includes the Pilar and Roça Grande mines, alongside a processing plant.
When to sell a stock?
Selling a stock is a critical decision for any investor. It’s often a delicate balance between locking in profits and potentially missing out on future gains. In today’s volatile market, it’s important to have a clear strategy to determine when to sell your stock.
The decision to sell a stock can be influenced by various factors, such as reaching a profit target, cutting losses, or reallocating assets. But it’s not just about the money, and it’s also about the timing. Selling at the right time can mean the difference between a successful investment and a missed opportunity.
Bruker Corporation (NASDAQ: BRKR): A Leader in Scientific Innovation and Reliability
Bruker Corporation (NASDAQ: BRKR) is a global leader in scientific instruments and diagnostic solutions, empowering researchers and industries to explore life, materials, and processes at the microscopic and molecular levels. Founded in 1960, the company offers a diverse portfolio of high-performance tools, including magnetic resonance systems, mass spectrometry, x-ray analysis, and spectroscopy technologies. These solutions are crucial in fields like life sciences, materials research, pharmaceuticals, and energy, enabling advancements in drug discovery, proteomics, nanotechnology, and more.
Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?
Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.
America’s Infrastructure Gap: Who Will Pay for the Next Decade of Investment?
America’s Infrastructure Challenge The United States has one of the world’s largest economies, yet much of its infrastructure is aging. Roads, bridges, airports, water systems, electricity networks, and public transit require significant investment to remain reliable and competitive. The challenge is no longer simply identifying what needs to be rebuilt. The bigger question is who…